| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2025 ( Subtotal = $0 ) |
| | 2025 | 2024 | UNIVERSITY OF OKLAHOMA | 660 PARRINGTON OVAL RM 301 | NORMAN | OK | 73019-3003 | CLEVELAND | USA | R35GM153297 | Multiscale Modeling of Enzymatic Reactions and Bioimaging Probes | 000 | 1 | NIH | 11/7/2024 | $0 |
| | 2025 | 2023 | UNIVERSITY OF OKLAHOMA | 660 PARRINGTON OVAL RM 301 | NORMAN | OK | 73019-3003 | CLEVELAND | USA | R25HG010132 | Programs for the Training and Advancement of the Next GENeration of Native Researchers in Genetics, Ethics and Society | 001 | 5 | NIH | 10/23/2024 | $0 |
| | 2025 | 2023 | UNIVERSITY OF OKLAHOMA | 660 PARRINGTON OVAL RM 301 | NORMAN | OK | 73019-3003 | CLEVELAND | USA | NH28CE003511 | McClain County Drug Free Communities | 01 | 2 | CDC | 10/2/2024 | $0 |
| | 2025 | 2022 | UNIVERSITY OF OKLAHOMA | 660 PARRINGTON OVAL RM 301 | NORMAN | OK | 73019-3003 | CLEVELAND | USA | R35GM127107 | Factors Influencing Scientific Research Careers among American Indians | 000 | 5 | NIH | 11/6/2024 | $0 |
| | 2025 | 2022 | UNIVERSITY OF OKLAHOMA | 660 PARRINGTON OVAL RM 301 | NORMAN | OK | 73019-3003 | CLEVELAND | USA | R25HG010132 | Programs for the Training and Advancement of the Next GENeration of Native Researchers in Genetics, Ethics and Society | 000 | 5 | NIH | 10/10/2024 | $0 |
|
| Issue Date FY: 2024 ( Subtotal = $9,986,262 ) (Continued on the next page) |
| | 2024 | 2024 | UNIVERSITY OF OKLAHOMA | 660 PARRINGTON OVAL RM 301 | NORMAN | OK | 73019-3003 | CLEVELAND | USA | P20GM135009 | Oklahoma Center of Medical Imaging for Translational Cancer Research | 000 | 3 | NIH | 1/3/2024 | $2,035,962 |
| | 2024 | 2024 | UNIVERSITY OF OKLAHOMA | 660 PARRINGTON OVAL RM 301 | NORMAN | OK | 73019-3003 | CLEVELAND | USA | R01CA269897 | Potentiating a systemic antitumor response by interstitial localized ablative immunotherapy to synergize with immune checkpoint therapy for metastatic pancreatic tumors | 000 | 3 | NIH | 3/8/2024 | $440,527 |
| | 2024 | 2024 | UNIVERSITY OF OKLAHOMA | 660 PARRINGTON OVAL RM 301 | NORMAN | OK | 73019-3003 | CLEVELAND | USA | R01CA269897 | Potentiating a systemic antitumor response by interstitial localized ablative immunotherapy to synergize with immune checkpoint therapy for metastatic pancreatic tumors | 001 | 3 | NIH | 4/17/2024 | $24,475 |
| | 2024 | 2024 | UNIVERSITY OF OKLAHOMA | 660 PARRINGTON OVAL RM 301 | NORMAN | OK | 73019-3003 | CLEVELAND | USA | F31HD113221 | Network mechanisms underlying core behavioral features in Fragile X Syndrome | 001 | 1 | NIH | 8/15/2024 | $0 |
| | 2024 | 2024 | UNIVERSITY OF OKLAHOMA | 660 PARRINGTON OVAL RM 301 | NORMAN | OK | 73019-3003 | CLEVELAND | USA | F31HD113221 | Network mechanisms underlying core behavioral features in Fragile X Syndrome | 000 | 1 | NIH | 8/15/2024 | $42,574 |
| | 2024 | 2024 | UNIVERSITY OF OKLAHOMA | 660 PARRINGTON OVAL RM 301 | NORMAN | OK | 73019-3003 | CLEVELAND | USA | RM1HG009042 | Center on the Ethics of Indigenous Genomic Research | 001 | 8 | NIH | 9/24/2024 | $561,142 |
| | 2024 | 2024 | UNIVERSITY OF OKLAHOMA | 660 PARRINGTON OVAL RM 301 | NORMAN | OK | 73019-3003 | CLEVELAND | USA | R01GM138800 | Acquisition of a Preparative High-Performance Liquid Chromatography (HPLC) System | 002 | 3 | NIH | 9/4/2024 | $105,000 |
| | 2024 | 2024 | UNIVERSITY OF OKLAHOMA | 660 PARRINGTON OVAL RM 301 | NORMAN | OK | 73019-3003 | CLEVELAND | USA | R01GM138800 | Acquisition of a Preparative High-Performance Liquid Chromatography (HPLC) System | 001 | 3 | NIH | 6/11/2024 | $29,071 |
| | 2024 | 2024 | UNIVERSITY OF OKLAHOMA | 660 PARRINGTON OVAL RM 301 | NORMAN | OK | 73019-3003 | CLEVELAND | USA | R01GM138800 | Acquisition of a Preparative High-Performance Liquid Chromatography (HPLC) System | 000 | 3 | NIH | 12/1/2023 | $261,643 |
| | 2024 | 2024 | UNIVERSITY OF OKLAHOMA | 660 PARRINGTON OVAL RM 301 | NORMAN | OK | 73019-3003 | CLEVELAND | USA | R01DC011579 | Taste and Somatosensory Processing | 001 | 13 | NIH | 5/2/2024 | $38,072 |
| | 2024 | 2024 | UNIVERSITY OF OKLAHOMA | 660 PARRINGTON OVAL RM 301 | NORMAN | OK | 73019-3003 | CLEVELAND | USA | R01DC011579 | Taste and Somatosensory Processing | 000 | 13 | NIH | 2/5/2024 | $342,645 |
| | 2024 | 2024 | UNIVERSITY OF OKLAHOMA | 660 PARRINGTON OVAL RM 301 | NORMAN | OK | 73019-3003 | CLEVELAND | USA | H79SP083220 | Strategic Prevention Framework for Prescription Drugs | 001 | 3 | SAMHSA | 7/16/2024 | $500,000 |
| | 2024 | 2024 | UNIVERSITY OF OKLAHOMA | 660 PARRINGTON OVAL RM 301 | NORMAN | OK | 73019-3003 | CLEVELAND | USA | R00ES033257 | Linking genomic, physiological, and behavioral responses using a Drosophila model of heavy metal stress | 001 | 4 | NIH | 8/14/2024 | $248,999 |
| | 2024 | 2024 | UNIVERSITY OF OKLAHOMA | 201 Stephenson Parkway | Norman | OK | 73019-9705 | CLEVELAND | USA | 90YR0133 | Happy Teacher Wellness Program to Support Head Start Staff's Well-Being | 00 | 4 | ACF | 7/8/2024 | $495,075 |
| | 2024 | 2024 | UNIVERSITY OF OKLAHOMA | 660 PARRINGTON OVAL RM 301 | NORMAN | OK | 73019-3003 | CLEVELAND | USA | R35GM147397 | A multi-level mass spectrometry pipeline for the analysis of whole proteoforms and their complexes | 000 | 3 | NIH | 7/2/2024 | $380,398 |
| | 2024 | 2024 | UNIVERSITY OF OKLAHOMA | 660 PARRINGTON OVAL RM 301 | NORMAN | OK | 73019-3003 | CLEVELAND | USA | NH28CE003511 | McClain County Drug Free Communities | 00 | 3 | CDC | 8/20/2024 | $125,000 |
| | 2024 | 2024 | UNIVERSITY OF OKLAHOMA | 660 PARRINGTON OVAL RM 301 | NORMAN | OK | 73019-3003 | CLEVELAND | USA | H79SP084324 | South Southwest Prevention Technology Transfer Center (SSW PTTC) | 000 | 1 | SAMHSA | 8/29/2024 | $739,529 |
| | 2024 | 2024 | UNIVERSITY OF OKLAHOMA | 660 PARRINGTON OVAL RM 301 | NORMAN | OK | 73019-3003 | CLEVELAND | USA | R01GM152704 | Light scattering device for the development of protein clouds | 001 | 1 | NIH | 6/12/2024 | $72,100 |
| | 2024 | 2024 | UNIVERSITY OF OKLAHOMA | 660 PARRINGTON OVAL RM 301 | NORMAN | OK | 73019-3003 | CLEVELAND | USA | K25CA270079 | Computational approaches to the mechanistic elucidation of the serrated pathway of human colon carcinogenesis | 000 | 2 | NIH | 7/12/2024 | $198,721 |
| | 2024 | 2024 | UNIVERSITY OF OKLAHOMA | 660 PARRINGTON OVAL RM 301 | NORMAN | OK | 73019-3003 | CLEVELAND | USA | R35GM150970 | Enabled by drug delivery: Studying the role of brain-resident and infiltrating myeloid cell phenotype in brain damage associated with inflammatory disease | 001 | 2 | NIH | 7/25/2024 | $373,297 |
| | 2024 | 2024 | UNIVERSITY OF OKLAHOMA | 660 PARRINGTON OVAL RM 301 | NORMAN | OK | 73019-3003 | CLEVELAND | USA | R35GM150758 | A novel framework for nanomedicine development | 000 | 2 | NIH | 7/25/2024 | $373,297 |
| | 2024 | 2024 | UNIVERSITY OF OKLAHOMA | 660 PARRINGTON OVAL RM 301 | NORMAN | OK | 73019-3003 | CLEVELAND | USA | R35GM151086 | Epigenetic and transcriptional mechanisms driving human pigmentation diversity | 001 | 2 | NIH | 7/2/2024 | $373,297 |
| | 2024 | 2024 | UNIVERSITY OF OKLAHOMA | 660 PARRINGTON OVAL RM 301 | NORMAN | OK | 73019-3003 | CLEVELAND | USA | P20GM135009 | Oklahoma Center of Medical Imaging for Translational Cancer Research | 001 | 3 | NIH | 5/16/2024 | $226,218 |
| | 2024 | 2024 | UNIVERSITY OF OKLAHOMA | 660 PARRINGTON OVAL RM 301 | NORMAN | OK | 73019-3003 | CLEVELAND | USA | R21EY036599 | Chromosome Packing Inhibitors for the Treatment of Eye Infections | 000 | 1 | NIH | 8/16/2024 | $201,825 |
| | 2024 | 2024 | UNIVERSITY OF OKLAHOMA | 660 PARRINGTON OVAL RM 301 | NORMAN | OK | 73019-3003 | CLEVELAND | USA | R35GM150970 | Enabled by drug delivery: Studying the role of brain-resident and infiltrating myeloid cell phenotype in brain damage associated with inflammatory disease | 000 | 1 | NIH | 4/30/2024 | $245,126 |
| | 2024 | 2024 | UNIVERSITY OF OKLAHOMA | 660 PARRINGTON OVAL RM 301 | NORMAN | OK | 73019-3003 | CLEVELAND | USA | P30GM145423 | Oklahoma COBRE in Structural Biology | 001 | 3 | NIH | 5/3/2024 | $1,141,533 |
| | 2024 | 2024 | UNIVERSITY OF OKLAHOMA | 660 PARRINGTON OVAL RM 301 | NORMAN | OK | 73019-3003 | CLEVELAND | USA | R01NS123051 | Single stage surgical intervention for treatment of severe traumatic brain injury | 002 | 3 | NIH | 5/3/2024 | $42,352 |
| | 2024 | 2024 | UNIVERSITY OF OKLAHOMA | 660 PARRINGTON OVAL RM 301 | NORMAN | OK | 73019-3003 | CLEVELAND | USA | R01AT011618 | Proteomic Stable Isotope Probing as a Novel Approach for Linking Prebiotics with Active Gut Microbiota | 000 | 4 | NIH | 5/21/2024 | $344,159 |
| | 2024 | 2024 | UNIVERSITY OF OKLAHOMA | 660 PARRINGTON OVAL RM 301 | NORMAN | OK | 73019-3003 | CLEVELAND | USA | R35GM153297 | Multiscale Modeling of Enzymatic Reactions and Bioimaging Probes | 000 | 1 | NIH | 5/17/2024 | $394,119 |
| | 2024 | 2024 | UNIVERSITY OF OKLAHOMA | 660 PARRINGTON OVAL RM 301 | NORMAN | OK | 73019-3003 | CLEVELAND | USA | R01AI132836 | Permeability barriers of Gram-negative pathogens and approaches to bypass them | 000 | 7 | NIH | 4/16/2024 | $463,073 |
| | 2024 | 2024 | UNIVERSITY OF OKLAHOMA | 660 PARRINGTON OVAL RM 301 | NORMAN | OK | 73019-3003 | CLEVELAND | USA | R03AI175981 | Characterizing mechanisms of immune protection by the bacterial type II-A CRISPR systems | 001 | 1 | NIH | 5/29/2024 | $7,099 |
| | 2024 | 2024 | UNIVERSITY OF OKLAHOMA | 660 PARRINGTON OVAL RM 301 | NORMAN | OK | 73019-3003 | CLEVELAND | USA | R01DC020843 | Temperature and thermogustatory preferences | 000 | 2 | NIH | 6/7/2024 | $477,443 |
| | 2024 | 2024 | UNIVERSITY OF OKLAHOMA | 660 PARRINGTON OVAL RM 301 | NORMAN | OK | 73019-3003 | CLEVELAND | USA | R35GM151086 | Epigenetic and transcriptional mechanisms driving human pigmentation diversity | 000 | 1 | NIH | 5/30/2024 | $249,817 |
| | 2024 | 2024 | UNIVERSITY OF OKLAHOMA | 660 PARRINGTON OVAL RM 301 | NORMAN | OK | 73019-3003 | CLEVELAND | USA | R21EY034326 | Characterizing the prevalence and nature of facial recognition deficits in non-proliferative diabetic retinopathy | 000 | 2 | NIH | 5/30/2024 | $206,229 |
| | 2024 | 2024 | UNIVERSITY OF OKLAHOMA | 660 PARRINGTON OVAL RM 301 | NORMAN | OK | 73019-3003 | CLEVELAND | USA | R01AI052293 | Transport across two membranes by AcrAB-TolC | 000 | 20 | NIH | 3/15/2024 | $493,895 |
| | 2024 | 2024 | UNIVERSITY OF OKLAHOMA | 660 PARRINGTON OVAL RM 301 | NORMAN | OK | 73019-3003 | CLEVELAND | USA | R01NS123051 | Single stage surgical intervention for treatment of severe traumatic brain injury | 001 | 3 | NIH | 2/23/2024 | $79,922 |
| | 2024 | 2024 | UNIVERSITY OF OKLAHOMA | 660 PARRINGTON OVAL RM 301 | NORMAN | OK | 73019-3003 | CLEVELAND | USA | R01NS123051 | Single stage surgical intervention for treatment of severe traumatic brain injury | 000 | 3 | NIH | 2/22/2024 | $544,518 |
| | 2024 | 2024 | UNIVERSITY OF OKLAHOMA | 660 PARRINGTON OVAL RM 301 | NORMAN | OK | 73019-3003 | CLEVELAND | USA | R03AI175981 | Characterizing mechanisms of immune protection by the bacterial type II-A CRISPR systems | 000 | 1 | NIH | 12/12/2023 | $63,891 |
| | 2024 | 2024 | UNIVERSITY OF OKLAHOMA | 660 PARRINGTON OVAL RM 301 | NORMAN | OK | 73019-3003 | CLEVELAND | USA | R01GM152704 | Light scattering device for the development of protein clouds | 000 | 1 | NIH | 1/15/2024 | $363,919 |
| | 2024 | 2023 | UNIVERSITY OF OKLAHOMA | 660 PARRINGTON OVAL RM 301 | NORMAN | OK | 73019-3003 | CLEVELAND | USA | U01MD017700 | The Effect of Medicaid Expansion on Mortality Disparities and Poverty | 000 | 2 | NIH | 10/10/2023 | $0 |
| | 2024 | 2023 | UNIVERSITY OF OKLAHOMA | 660 PARRINGTON OVAL RM 301 | NORMAN | OK | 73019-3003 | CLEVELAND | USA | U01MD017700 | The Effect of Medicaid Expansion on Mortality Disparities and Poverty | 001 | 2 | NIH | 2/8/2024 | -$329,606 |
| | 2024 | 2023 | UNIVERSITY OF OKLAHOMA | 660 PARRINGTON OVAL RM 301 | NORMAN | OK | 73019-3003 | CLEVELAND | USA | R21AR079705 | Peptide Discovery for Chondrogenesis | 000 | 2 | NIH | 7/5/2024 | $0 |
| | 2024 | 2023 | UNIVERSITY OF OKLAHOMA | 660 PARRINGTON OVAL RM 301 | NORMAN | OK | 73019-3003 | CLEVELAND | USA | R01AI141625 | Quantitative Analysis of Serum Autoantibody Repertories in Systemic Lupus Erythematosus | 000 | 5 | NIH | 7/19/2024 | $0 |
|
